Article Text
Abstract
Compared with mainstream medicine and complementary and alternative therapies, the practice of psychotherapy has enjoyed a relative pass when it comes to ethical evaluation. Therefore, contributions to the, although slowly growing, body of literature on psychotherapy ethics are to be welcomed. In his paper ‘Psychotherapy, placebos, and informed consent’, Garson Leder takes issue with what he calls the ‘go open’ project in psychotherapy ethics—the idea that the so-called ‘common factors’ in therapy should be disclosed to prospective patients. Although Leder does not give a detailed list, the common factors include therapist characteristics (empathy, positive regard, positive expectations that therapy will succeed), patient characteristics (expectations about therapy including its plausibility, confidence in the therapist), and the working alliance (how well both therapist and patient work well together during sessions). He argues that the project advocating disclosure of these factors is flawed on two grounds: (1) that information about common factors is not necessary for informed consent; and (2) clarity about specific mechanisms of change in therapy is consistent with ‘many theory-specific forms of psychotherapy’. There are multiple serious problems with Leder’s critique of the recent literature, including how he represents the contours of the debate, which I list, and address in this response.
- psychotherapy
- applied and professional ethics
- informed consent
- psychiatry
- clinical ethics
Statistics from Altmetric.com
Footnotes
Twitter @crblease
Collaborators Not applicable.
Contributors CB is sole author of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Not commissioned; internally peer reviewed.
Linked Articles
- Clinical ethics
Read the full text or download the PDF:
Other content recommended for you
- Psychotherapy, placebos, and informed consent
- How to obtain informed consent for psychotherapy: a reply to criticism
- All you need is cognitive behaviour therapy?
- Cost and outcome of behavioural activation versus cognitive behavioural therapy for depression (COBRA): a qualitative process evaluation
- Talking more about talking cures: cognitive behavioural therapy and informed consent
- Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis
- Moving from tradition-based to competence-based psychotherapy
- Complementary therapies for clinical depression: an overview of systematic reviews
- Open therapy and its enemies
- Pharmacological and non-pharmacological treatments for major depressive disorder: review of systematic reviews